Table 1

Characteristics of study participants at diagnosis

EtanerceptPlacebo
Sex (male/female)8/23/5
Age (years)12.5 ± 3.312.4 ± 3.6
Height (cm)154.4 ± 18.3152.1 ± 16.6
Weight (kg)51.1 ± 19.749.2 ± 15.9
Insulin (units · kg−1 · day−1)40.4 ± 22.339.6 ± 20.5
A1C (%)12.8 ± 3.212.4 ± 2.5
C-peptide (ng/ml)0.9 ± 0.41.1 ± 0.8
Diabetes duration (days)21.4 ± 4.428.5 ± 7.5
  • Data are means ± SD.